These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 18186523

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
    Poon MC, Zotz R, Di Minno G, Abrams ZS, Knudsen JB, Laurian Y.
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383
    [Abstract] [Full Text] [Related]

  • 23. Surgical procedures in patients with Glanzmann's thrombasthenia: case series and literature review.
    Ganapule A, Jain P, Abubacker FN, Korula A, Abraham A, Mammen J, George B, Mathews V, Srivastava A, Viswabandya A.
    Blood Coagul Fibrinolysis; 2017 Mar; 28(2):171-175. PubMed ID: 27273143
    [Abstract] [Full Text] [Related]

  • 24. Thromboelastographic evaluation of recombinant factor VIIa in a child with Glanzmann's thrombasthenia.
    Ismael F, van der Meer J, de Wolf JT, Kuizenga K, Aarts LP, Hendriks HG.
    Anesth Analg; 2006 Sep; 103(3):791-2. PubMed ID: 16931713
    [No Abstract] [Full Text] [Related]

  • 25. The use of recombinant factor VIIa in a patient with severe Glanzmann's thrombasthenia to facilitate insertion of a Port-a-Cath.
    Ancliff P, Liesner R, Khair K, Hann I.
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):447-8. PubMed ID: 10695773
    [No Abstract] [Full Text] [Related]

  • 26. Feminizing Genitoplasty in a young girl with Glanzmann's thrombasthenia-management of haemostasis.
    Turk KK, Nazir Z.
    J Pak Med Assoc; 2020 Jun; 70(6):1084-1085. PubMed ID: 32810113
    [Abstract] [Full Text] [Related]

  • 27. [Glanzmann thrombasthenia and pregnancy--report of a case and literature review].
    Uchikova E, Pechlivanov B, Parahuleva N, Amaliev G.
    Akush Ginekol (Sofiia); 2014 Jun; 53(5):49-51. PubMed ID: 25558673
    [Abstract] [Full Text] [Related]

  • 28. Dental considerations for a Glanzmann's thrombasthenia patient: case report.
    Bisch FC, Bowen KJ, Hanson BS, Kudryk VL, Billman MA.
    J Periodontol; 1996 May; 67(5):536-40. PubMed ID: 8724714
    [Abstract] [Full Text] [Related]

  • 29. Hyperplastic polyps of the gastric antrum in patients with gastrointestinal blood loss.
    Al-Haddad M, Ward EM, Bouras EP, Raimondo M.
    Dig Dis Sci; 2007 Jan; 52(1):105-9. PubMed ID: 17151810
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Use of recombinant factor VIIa for post-operative haemorrhage in a patient with Glanzmann's thrombasthenia and human leucocyte antigen antibodies.
    Patel RK, Savidge GF, Rangarajan S.
    Br J Haematol; 2001 Jul; 114(1):245-6. PubMed ID: 11472380
    [No Abstract] [Full Text] [Related]

  • 32. Glanzmann's thrombasthenia proposed optimal management during surgery and delivery.
    Bell JA, Savidge GF.
    Clin Appl Thromb Hemost; 2003 Apr; 9(2):167-70. PubMed ID: 12812388
    [Abstract] [Full Text] [Related]

  • 33. Norethisterone therapy for bleeding due to gastrointestinal telangiectases in Glanzmann's thrombasthenia.
    Leach M, Makris M, Hampton KK, Preston FE.
    Br J Haematol; 1998 Mar; 100(3):594-6. PubMed ID: 9504647
    [Abstract] [Full Text] [Related]

  • 34. Perioperative administration of recombinant activated factor VII in a Glanzmann's thrombasthenia patient with platelet refractoriness: case report.
    Bisinotto FMB, Martins LB, de Camargos GP, Bianco MP.
    Braz J Anesthesiol; 2022 Mar; 72(6):823-825. PubMed ID: 34852265
    [Abstract] [Full Text] [Related]

  • 35. Factor VIII/von Willebrand factor concentrate for treatment of life threatening epistaxis in Glanzmann's thrombasthenia.
    Zinke RA, Ornstein DL, Holmes CE.
    Haemophilia; 2010 Jul 01; 16(4):701-4. PubMed ID: 20331758
    [No Abstract] [Full Text] [Related]

  • 36. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey.
    Poon MC, D'Oiron R, Von Depka M, Khair K, Négrier C, Karafoulidou A, Huth-Kuehne A, Morfini M, International Data Collection on Recombinant Factor VIIa and Congenital Platelet Disorders Study Group.
    J Thromb Haemost; 2004 Jul 01; 2(7):1096-103. PubMed ID: 15219192
    [Abstract] [Full Text] [Related]

  • 37. A case of Glanzmann's thrombasthenia successfully treated with recombinant factor viia during a surgical procedure: observations on the monitoring and the mechanism of action of this drug.
    Dargaud Y, Bordet JC, Trzeciak MC, Vinciguerra C, Negrier C.
    Haematologica; 2006 Jun 01; 91(6 Suppl):ECR20. PubMed ID: 16785139
    [Abstract] [Full Text] [Related]

  • 38. Glanzmann's thrombasthenia in two pregnant females.
    Dede M, Ural AU, Yenen M, Mesten Z, Baser I.
    Am J Hematol; 2007 Apr 01; 82(4):330-1. PubMed ID: 17013816
    [No Abstract] [Full Text] [Related]

  • 39. Recombinant activated factor VII combined with desmopressin in preventing bleeding from dental extraction in a patient with Glanzmann's thrombasthenia.
    Lombardo VT, Sottilotta G.
    Clin Appl Thromb Hemost; 2006 Jan 01; 12(1):115-6. PubMed ID: 16444446
    [Abstract] [Full Text] [Related]

  • 40. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
    Cağlar K, Cetinkaya A, Aytaç S, Gümrük F, Gürgey A.
    Pediatr Hematol Oncol; 2003 Sep 01; 20(6):435-8. PubMed ID: 14631616
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.